Trials that use: Interim analysis / alpha spending
New to this method? Read the tutorial →
11,819 results
- MDs on Botox Utility (MOBILITY): Complete Statistical AnalysisIndependent statistical analysis of MDs on Botox Utility (MOBILITY): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00535938).
- MDS-005Independent statistical analysis of A Study of Lenalidomide Versus Placebo in Subjects With Transfusion Dependent Anemia in Lower Risk Myelodysplastic Syndrome (MDS) Without Del 5q: primary endpoint results, effect estimate with confidence…
- MDX-010 in Treating Patients With Stage IV Pancreatic Cancer That Cannot Be Removed By Surgery: Complete Statistical AnalysisIndependent statistical analysis of MDX-010 in Treating Patients With Stage IV Pancreatic Cancer That Cannot Be Removed By Surgery: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety,…
- MEACIndependent statistical analysis of Minimum Effective Concentration of Ropivacaine for Brachial Plexus Block Via the Supraclavicular and Infraclavicular Approach, Femoral Nerve Block, Sciatic Nerve Block Via the Popliteal and Parasacral Approach: primary…
- MEASURE 1 extIndependent statistical analysis of Extension in AS: Sustainability of Benefits, Safety and Tolerability: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01863732).
- Measurement of Relaxin Peptide in Multiple Sclerosis (MS): Complete Statistical AnalysisIndependent statistical analysis of Measurement of Relaxin Peptide in Multiple Sclerosis (MS): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01909492).
- Measurements of Body Iron Excretion of Healthy Adults: Complete Statistical AnalysisIndependent statistical analysis of Measurements of Body Iron Excretion of Healthy Adults: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00755105).
- Measuring Fatty Acid Oxidation in Gliomas Using 18F-FPIA PET/MRI: Complete Statistical AnalysisIndependent statistical analysis of Measuring Fatty Acid Oxidation in Gliomas Using 18F-FPIA PET/MRI: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT04097535).
- Measuring Intraabdominal Pressure, Lactic Acid, and Urine Output: Complete Statistical AnalysisIndependent statistical analysis of Measuring Intraabdominal Pressure, Lactic Acid, and Urine Output: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT05070572).
- Measuring the Amount of Methadone or Morphine in the Blood of Neonates, Infants & Children After Cardiac Surgery.: Complete Statistical AnalysisIndependent statistical analysis of Measuring the Amount of Methadone or Morphine in the Blood of Neonates, Infants & Children After Cardiac Surgery.: primary endpoint results, effect estimate with confidence interval, sample-size planning…
- Mecamylamine for the Treatment of Patients With Depression and Alcohol Dependence: Complete Statistical AnalysisIndependent statistical analysis of Mecamylamine for the Treatment of Patients With Depression and Alcohol Dependence: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…
- Mechanism of Action of Ocrelizumab in Multiple Sclerosis: Complete Statistical AnalysisIndependent statistical analysis of Mechanism of Action of Ocrelizumab in Multiple Sclerosis: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03344094).
- Mechanisms and Treatment of Chronic Allograft Injury (CAI) Due to Calcineurin Inhibitor (CNI) Toxicity: Complete Statistical AnalysisIndependent statistical analysis of Mechanisms and Treatment of Chronic Allograft Injury (CAI) Due to Calcineurin Inhibitor (CNI) Toxicity: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based…
- Mechanisms of Antidepressant Non-Response in Late-Life Depression: Complete Statistical AnalysisIndependent statistical analysis of Mechanisms of Antidepressant Non-Response in Late-Life Depression: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01931202).
- Mechanisms of Belatacept Effect on Alloimmunity and Antiviral Response After Kidney Transplantation (BMS IM 103-309): Complete Statistical AnalysisIndependent statistical analysis of Mechanisms of Belatacept Effect on Alloimmunity and Antiviral Response After Kidney Transplantation (BMS IM 103-309): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety,…
- Mechanisms of CBD for Chronic Pain: Complete Statistical AnalysisIndependent statistical analysis of Mechanisms of CBD for Chronic Pain: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT04044729).
- Mechanisms of Change, Motivation, and Treatment Outcome in Alcohol Dependence – Posttraumatic Stress Disorder: Complete Statistical AnalysisIndependent statistical analysis of Mechanisms of Change, Motivation, and Treatment Outcome in Alcohol Dependence - Posttraumatic Stress Disorder: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based…
- Mechanisms of Chronic Kidney Disease (CKD)-Induced Foam Cell Formation: Complete Statistical AnalysisIndependent statistical analysis of Mechanisms of Chronic Kidney Disease (CKD)-Induced Foam Cell Formation: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01671605).
- Mechanisms of Hypertension in Women With Polycystic Ovary Syndrome: Complete Statistical AnalysisIndependent statistical analysis of Mechanisms of Hypertension in Women With Polycystic Ovary Syndrome: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT04327934).
- Mechanisms of Immune Reconstitution & Reduced Immune Activation Following Darunavir-based ART: Complete Statistical AnalysisIndependent statistical analysis of Mechanisms of Immune Reconstitution & Reduced Immune Activation Following Darunavir-based ART: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…
- Mechanisms of Refractory Hypertension (Reserpine): Complete Statistical AnalysisIndependent statistical analysis of Mechanisms of Refractory Hypertension (Reserpine): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03223272).
- Mechanistic Drivers of Acute PAPE Responsiveness: Muscle Architecture, Contractile Kinetics, and Excitability in a Randomized Controlled Trial: Complete Statistical AnalysisIndependent statistical analysis of Mechanistic Drivers of Acute PAPE Responsiveness: Muscle Architecture, Contractile Kinetics, and Excitability in a Randomized Controlled Trial: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration,…
- MeCISIndependent statistical analysis of MethaCholine Bronchoprovocation Study (MeCIS): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00705341).
- MEDALISTIndependent statistical analysis of A Study of Luspatercept (ACE-536) to Treat Anemia Due to Very Low, Low, or Intermediate Risk Myelodysplastic Syndromes: primary endpoint results, effect estimate with confidence interval, sample-size planning…
- MEDI4736 and Tremelimumab in Treating Patients With Metastatic HER2 Negative Breast Cancer: Complete Statistical AnalysisIndependent statistical analysis of MEDI4736 and Tremelimumab in Treating Patients With Metastatic HER2 Negative Breast Cancer: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov…
- MediBeat – HeartBeat Observation Trial: Complete Statistical AnalysisIndependent statistical analysis of MediBeat - HeartBeat Observation Trial: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT04082819).
- MEDIC-1Independent statistical analysis of Pharmacist-led Group Medical Visits to Help With Diabetes Management: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00554671).
- Medication Development for Protracted Abstinence in Alcoholism: CORT118335 Versus Placebo: Complete Statistical AnalysisIndependent statistical analysis of Medication Development for Protracted Abstinence in Alcoholism: CORT118335 Versus Placebo: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT04466215).
- Medication Treatment for Depression in Nursing Home Residents: Complete Statistical AnalysisIndependent statistical analysis of Medication Treatment for Depression in Nursing Home Residents: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00076622).
- Medications for Stopping Cocaine Dependence and Preventing Relapse: Complete Statistical AnalysisIndependent statistical analysis of Medications for Stopping Cocaine Dependence and Preventing Relapse: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00218023).
- MediGuide Registry: Complete Statistical AnalysisIndependent statistical analysis of MediGuide Registry: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02470312).
- Medtronic Transcatheter Aortic Valve Replacement (TAVR) Low Risk Bicuspid Study: Complete Statistical AnalysisIndependent statistical analysis of Medtronic Transcatheter Aortic Valve Replacement (TAVR) Low Risk Bicuspid Study: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03635424).
- Mel47Independent statistical analysis of Temsirolimus and Bevacizumab in Treating Patients With Stage III or Stage IV Malignant Melanoma: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based…
- Mel55Independent statistical analysis of Study to Assess Safety and Immune Response of Stage IIB-IV Resected Melanoma After Treatment With MAGE-A3 ASCI: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration,…
- MelaOstrongIndependent statistical analysis of Melatonin and Osteogenic Loading on Osteopenia: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT04233112).
- Melatonin in Smoke-induced Vascular Injury: Complete Statistical AnalysisIndependent statistical analysis of Melatonin in Smoke-induced Vascular Injury: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02591238).
- Melatonin Intervention For Neurocognitive Deficits in the St. Jude Lifetime Cohort: Complete Statistical AnalysisIndependent statistical analysis of Melatonin Intervention For Neurocognitive Deficits in the St. Jude Lifetime Cohort: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…
- Melatonin Postoperative Sleep Study in Breast Cancer Patients: Complete Statistical AnalysisIndependent statistical analysis of Melatonin Postoperative Sleep Study in Breast Cancer Patients: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00506064).
- Melatonin Supplementation for Cancer-related Fatigue in Patients Receiving Radiotherapy: Complete Statistical AnalysisIndependent statistical analysis of Melatonin Supplementation for Cancer-related Fatigue in Patients Receiving Radiotherapy: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02332928).
- Melphalan and Bortezomib Prior to Autologous Stem Cell Transplant in Treating Patients With Multiple Myeloma: Complete Statistical AnalysisIndependent statistical analysis of Melphalan and Bortezomib Prior to Autologous Stem Cell Transplant in Treating Patients With Multiple Myeloma: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety,…
- MELTEMIIndependent statistical analysis of A Safety Extension Study With Benralizumab for Asthmatic Adults on Inhaled Corticosteroid Plus Long-acting β2 Agonist: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and…
- Memantine Augmentation of Lamotrigine Incomplete-Response in Bipolar Depression: Complete Statistical AnalysisIndependent statistical analysis of Memantine Augmentation of Lamotrigine Incomplete-Response in Bipolar Depression: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00305578).
- Memantine for Executive Dysfunction in Adults With ADHD: A Pilot Study: Complete Statistical AnalysisIndependent statistical analysis of Memantine for Executive Dysfunction in Adults With ADHD: A Pilot Study: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…
- Memantine-enhanced Buprenorphine Treatment for Opioid-dependent Young Adults: Complete Statistical AnalysisIndependent statistical analysis of Memantine-enhanced Buprenorphine Treatment for Opioid-dependent Young Adults: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01052662).
- MEMOIndependent statistical analysis of Safety and Efficacy of Sequential Therapy With Mexidol® in Patients With Chronic Cerebral Ischemia: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based…
- Memory and Attention Adaptation Training-Geriatrics (MAAT-G): Complete Statistical AnalysisIndependent statistical analysis of Memory and Attention Adaptation Training-Geriatrics (MAAT-G): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT04230941).
- Men Together Making a Difference: Reducing HIV/STD Risk Behavior Among South African Men: Complete Statistical AnalysisIndependent statistical analysis of Men Together Making a Difference: Reducing HIV/STD Risk Behavior Among South African Men: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on…
- MENDEL-2Independent statistical analysis of Monoclonal Antibody Against PCSK9 to Reduce Elevated LDL-C in Subjects Currently Not Receiving Drug Therapy for Easing Lipid Levels-2: primary endpoint results, effect estimate with confidence interval, sample-size…
- Menopur® Versus Follistim® in Polycystic Ovarian Syndrome (PCOS): Complete Statistical AnalysisIndependent statistical analysis of Menopur® Versus Follistim® in Polycystic Ovarian Syndrome (PCOS): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00805935).
- MEQIndependent statistical analysis of Study of the Validity of Using the MEQ to Measure Mindful Eating in Pregnant Women: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety,…